Comparative efficacy of oral hypoglycemic agents to be added to biphasic insulin aspart-70 (BIAsp70) in Japanese type 2 diabetic patients by using continuous glucose monitoring system (CGMS)

Comparative efficacy of oral hypoglycemic agents to be added to biphasic insulin aspart-70 (BIAsp70) in Japanese type 2 diabetic patients by using continuous glucose monitoring system (CGMS) - Comparative efficacy of oral hypoglycemic agents to be added to biphasic insulin aspart-70 (BIAsp70) in Japanese type 2 diabetic patients by using continuous glucose monitoring system (CGMS)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010311

Enrollment

Registered

2013-03-25

Start date

2011-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T2DM

Interventions

BIAsp70 Addition of glimepiride (0.5 mg/day) to the BIAsp70 Addition of metformin (500 mg/day) to the BIAsp70

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: T2DM

Exclusion criteria

Exclusion criteria: 1. Pregnant or intention of becoming pregnant 2. Patients who are judged by investigators to be inappropriate for inclusion in the study

Design outcomes

Primary

Measure	Time frame
1) Pre-breakfast blood glucose 2) Average of the blood glucose 3) Variability of the blood glucose	—

Secondary

Measure	Time frame
Frequency of hypoglycemia	—

Countries

Japan

Contacts

Public ContactYoshio Nagai

St. Marianna University School of Medicine Division of Metabolism and Endocrinology, Department of Internal Medicine

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026